rs2336573

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016579.4(CD320):​c.658G>A​(p.Gly220Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0503 in 1,613,920 control chromosomes in the GnomAD database, including 4,826 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G220G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.11 ( 2030 hom., cov: 32)
Exomes 𝑓: 0.044 ( 2796 hom. )

Consequence

CD320
NM_016579.4 missense

Scores

1
2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.237

Publications

54 publications found
Variant links:
Genes affected
CD320 (HGNC:16692): (CD320 molecule) This gene encodes the transcobalamin receptor that is expressed at the cell surface. It mediates the cellular uptake of transcobalamin bound cobalamin (vitamin B12), and is involved in B-cell proliferation and immunoglobulin secretion. Mutations in this gene are associated with methylmalonic aciduria. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2011]
CD320 Gene-Disease associations (from GenCC):
  • methylmalonic acidemia due to transcobalamin receptor defect
    Inheritance: Unknown, AR Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0048907995).
BP6
Variant 19-8302825-C-T is Benign according to our data. Variant chr19-8302825-C-T is described in ClinVar as Benign. ClinVar VariationId is 136684.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.299 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CD320NM_016579.4 linkc.658G>A p.Gly220Arg missense_variant Exon 4 of 5 ENST00000301458.10 NP_057663.1
CD320NM_001165895.2 linkc.532G>A p.Gly178Arg missense_variant Exon 3 of 4 NP_001159367.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CD320ENST00000301458.10 linkc.658G>A p.Gly220Arg missense_variant Exon 4 of 5 1 NM_016579.4 ENSP00000301458.4

Frequencies

GnomAD3 genomes
AF:
0.114
AC:
17351
AN:
151968
Hom.:
2022
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.303
Gnomad AMI
AF:
0.0230
Gnomad AMR
AF:
0.0684
Gnomad ASJ
AF:
0.0580
Gnomad EAS
AF:
0.0882
Gnomad SAS
AF:
0.0398
Gnomad FIN
AF:
0.0297
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0348
Gnomad OTH
AF:
0.104
GnomAD2 exomes
AF:
0.0585
AC:
14701
AN:
251172
AF XY:
0.0532
show subpopulations
Gnomad AFR exome
AF:
0.308
Gnomad AMR exome
AF:
0.0456
Gnomad ASJ exome
AF:
0.0633
Gnomad EAS exome
AF:
0.0884
Gnomad FIN exome
AF:
0.0273
Gnomad NFE exome
AF:
0.0344
Gnomad OTH exome
AF:
0.0486
GnomAD4 exome
AF:
0.0437
AC:
63861
AN:
1461838
Hom.:
2796
Cov.:
34
AF XY:
0.0425
AC XY:
30872
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.311
AC:
10425
AN:
33472
American (AMR)
AF:
0.0480
AC:
2148
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0611
AC:
1597
AN:
26136
East Asian (EAS)
AF:
0.0728
AC:
2889
AN:
39698
South Asian (SAS)
AF:
0.0346
AC:
2985
AN:
86258
European-Finnish (FIN)
AF:
0.0283
AC:
1510
AN:
53418
Middle Eastern (MID)
AF:
0.0666
AC:
384
AN:
5768
European-Non Finnish (NFE)
AF:
0.0345
AC:
38332
AN:
1111968
Other (OTH)
AF:
0.0595
AC:
3591
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
3562
7123
10685
14246
17808
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1674
3348
5022
6696
8370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.114
AC:
17381
AN:
152082
Hom.:
2030
Cov.:
32
AF XY:
0.113
AC XY:
8408
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.303
AC:
12556
AN:
41440
American (AMR)
AF:
0.0683
AC:
1043
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0580
AC:
201
AN:
3466
East Asian (EAS)
AF:
0.0884
AC:
456
AN:
5156
South Asian (SAS)
AF:
0.0396
AC:
191
AN:
4826
European-Finnish (FIN)
AF:
0.0297
AC:
315
AN:
10616
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0348
AC:
2364
AN:
67990
Other (OTH)
AF:
0.102
AC:
214
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
684
1368
2051
2735
3419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0583
Hom.:
2846
Bravo
AF:
0.127
TwinsUK
AF:
0.0372
AC:
138
ALSPAC
AF:
0.0350
AC:
135
ESP6500AA
AF:
0.312
AC:
1374
ESP6500EA
AF:
0.0386
AC:
332
ExAC
AF:
0.0634
AC:
7691
Asia WGS
AF:
0.0820
AC:
286
AN:
3478
EpiCase
AF:
0.0425
EpiControl
AF:
0.0385

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 26, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Methylmalonic acidemia due to transcobalamin receptor defect Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
8.6
DANN
Benign
0.81
DEOGEN2
Benign
0.10
.;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.025
N
LIST_S2
Benign
0.50
T;T
MetaRNN
Benign
0.0049
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.1
.;L
PhyloP100
0.24
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-2.5
D;N
REVEL
Benign
0.23
Sift
Uncertain
0.0010
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.27
.;B
Vest4
0.15
MutPred
0.073
.;Loss of catalytic residue at A219 (P = 0.0641);
MPC
0.15
ClinPred
0.014
T
GERP RS
-2.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.074
gMVP
0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2336573; hg19: chr19-8367709; COSMIC: COSV56848201; COSMIC: COSV56848201; API